lenalidomide has been researched along with Granulocytic Leukemia, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, B; Mu, Q; Ouyang, G; Sheng, L; Wang, Y; Xu, K; Zhang, Y; Zhu, H | 1 |
| Branford, S; Carne, L; Clarson, J; Dang, P; Hughes, TP; Irani, YD; Leclercq, T; McLean, J; Pagani, IS; Reynolds, J; Ritchie, DS; Ross, DM; Saunders, VA; White, DL; Yong, ASM | 1 |
| Binder, M; Bornhäuser, M; Ehninger, G; Mohr, B; Platzbecker, U; Schetelig, J; von Bonin, M | 1 |
1 trial(s) available for lenalidomide and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia.
Topics: Aged; Female; Humans; Imatinib Mesylate; Immunologic Factors; Lenalidomide; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Maintenance Chemotherapy; Male; Middle Aged; Treatment Outcome | 2019 |
2 other study(ies) available for lenalidomide and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Durable remission in a patient of mixed phenotype acute leukemia with Philadelphia chromosome-positive treated with nilotinib and lenalidomide: A case report.
Topics: Acute Disease; Antineoplastic Agents; Drug Therapy, Combination; Humans; Induction Chemotherapy; Lenalidomide; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Maintenance Chemotherapy; Male; Middle Aged; Phenotype; Philadelphia Chromosome; Pyrimidines; Thalidomide | 2018 |
Lenalidomide as induction therapy before allogeneic stem cell transplantation in a patient with proliferative CMML-2 and del(5q) not involving the EGR1 locus.
Topics: Aged; Antineoplastic Agents; Cell Proliferation; Chromosomes, Human, Pair 5; Cytogenetics; Early Growth Response Protein 1; Gene Deletion; Humans; Lenalidomide; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Remission Induction; Stem Cell Transplantation; Thalidomide; Time Factors; Transplantation, Homologous | 2007 |